Tumor volume reduction using combined phacoemulsification and intravitreal triamcinolone injection for the management of cataract with treated uveal melanoma and atypical nevi

Colleen M. Cebulla, Armando M. Alegret, William J. Feuer, Wei Shi, Amy C. Schefler, Timothy G. Murray

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Purpose: To study the reduction in tumor size and the safety and efficacy of combined phacoemulsification and intravitreal triamcinolone acetonide injection (phaco-IVTA) in patients with treated melanoma and atypical nevi. Setting: Bascom Palmer Eye Institute, Miami, Florida, USA. Methods: The medical records of 49 consecutive patients (51 eyes) with treated melanoma or atypical nevi treated with phaco-IVTA were evaluated retrospectively for changes in Snellen visual acuity, tumor volume, and frequency of complications. Main outcome measures included a postsurgical change in tumor size greater than or equal to 0.5 mm of height or 1.0 mm of basal diameter by echographic analysis, improvement in visual acuity at 6 months and final follow-up, and complications including endophthalmitis, cystoid macular edema, epiretinal membrane, increased intraocular pressure, and persistent corneal edema. Results: The median baseline visual acuity was 20/80 in the affected eye. At the 6-month follow-up examination, 13 (68%) of 19 eyes had achieved better than 20/40 visual acuity. Treated uveal melanomas (n = 30) and atypical choroidal nevi (n = 21) were stable with combined therapy, and echographic measurements improved in 12 eyes. Intraocular pressure increased from baseline to 25 mm Hg or more postoperatively in 4 of 51 eyes (8%). No other significant complications occurred. Conclusions: Combined phacoemulsification and IVTA was reasonably safe in patients with treated melanoma and atypical nevi. Tumors remained stable or decreased slightly in size. Intravitreal triamcinolone acetonide injection at the time of cataract surgery in patients with treated melanoma or nevus may reduce rates of tumor progression in these patients.

Original languageEnglish (US)
Pages (from-to)1669-1673
Number of pages5
JournalJournal of cataract and refractive surgery
Volume34
Issue number10
DOIs
StatePublished - Oct 1 2008

ASJC Scopus subject areas

  • Surgery
  • Ophthalmology
  • Sensory Systems

Fingerprint Dive into the research topics of 'Tumor volume reduction using combined phacoemulsification and intravitreal triamcinolone injection for the management of cataract with treated uveal melanoma and atypical nevi'. Together they form a unique fingerprint.

  • Cite this